While these symptoms can also be caused by other conditions, maintaining good overall health and avoiding risk factors can help reduce the chances of a late-stage lung cancer diagnosis.

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Increased use of chest X-rays leads to earlier lung ... diagnose cancer at an earlier stage to give people affected by cancer ...